BioScrip to Participate in Upcoming Investor Conferences

BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf, President and Chief Executive Officer, and Stephen M. Deitsch, Senior Vice President, Chief Financial Officer and Treasurer, will participate in the following upcoming investor conferences:

The 15th Annual Craig-Hallum Institutional Investor ConferenceMinneapolis, MinnesotaWednesday, May 30, 2018One-on-one and small group meetings only

The Jefferies 2018 Global Healthcare ConferenceNew York, New YorkWednesday, June 6, 2018Group presentation – 10:30 a.m. ET

A live webcast of the Jefferies group presentation and copies of the materials presented can be accessed via BioScrip’s Investor Relations website at https://investors.bioscrip.com/ or through the following link http://wsw.com/webcast/jeff113/bios/.

About BioScrip, Inc.

BioScrip, Inc. is the largest independent national provider of infusion and home care management solutions, with approximately 2,200 teammates and nearly 80 service locations across the U.S. BioScrip partners with physicians, hospital systems, payors, pharmaceutical manufacturers and skilled nursing facilities to provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.

Investor Contacts:
Stephen Deitsch Chief Financial Officer & Treasurer T:  [phone] [e-mail]	Kalle Ahl, CFAThe Equity GroupT:  (212) [e-mail]